Eterna Therapeutics (ERNA) Financial Statements
Eterna Therapeutics Financial Overview
Eterna Therapeutics's market cap is currently $3.22M. The company's EPS TTM is $-18.85; its P/E ratio is -0.10; Eterna Therapeutics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 582.00K | $ 68.00K | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 486.00K | $ -168.00K | $ 0.00 | $ 0.00 |
| Operating Income | $ -9.32M | $ -15.67M | $ -21.14M | $ -33.22M | $ -113.73M |
| EBITDA | $ -13.84M | $ -36.12M | $ -19.93M | $ -24.01M | $ -121.95M |
| Net Income | $ -14.08M | $ -44.54M | $ -21.67M | $ -24.58M | $ -122.55M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.88M | $ 1.73M | $ 7.58M | $ 11.45M | $ 16.98M |
| Total Assets | $ 5.83M | $ 5.27M | $ 49.13M | $ 22.28M | $ 31.52M |
| Total Debt | $ 490.00K | $ 684.00K | $ 41.84M | $ 4.14M | $ 2.72M |
| Net Debt | $ -1.39M | $ -1.04M | $ 34.27M | $ -7.31M | $ -14.26M |
| Total Liabilities | $ 3.43M | $ 3.57M | $ 46.90M | $ 10.17M | $ 6.02M |
| Stockholders' Equity | $ 2.40M | $ 1.70M | $ 2.23M | $ 12.11M | $ 25.50M |
| Cash Flow | |||||
| Free Cash Flow | $ -7.05M | $ -16.20M | $ -20.43M | $ -21.27M | $ -23.64M |
| Operating Cash Flow | $ -7.02M | $ -15.84M | $ -20.41M | $ -20.98M | $ -23.49M |
| Investing Cash Flow | $ -37.00K | $ -365.00K | $ -19.00K | $ -47.00K | $ -22.74M |
| Financing Cash Flow | $ 7.21M | $ 6.26M | $ 16.56M | $ 19.58M | $ 61.59M |
Currency in USD
